Add office photos
Employer?
Claim Account for FREE
Boehringer-Ingelheim
4.0
based on 302 Reviews
Video summary
Company Overview
Company Locations
Working at Boehringer-Ingelheim
Company Summary
Boehringer-Ingelheim is a research-based pharmaceutical firm dedicated to developing innovative therapies for unmet medical needs in human and animal health.
Overall Rating
4.0/5
based on 302 reviews
3% above
industry average
Highly rated for
Salary, Work-life balance, Skill development
Critically rated for
Job security, Promotions
Work Policy
Work from office
45% employees reported
Monday to Saturday
41% employees reported
Flexible timing
84% employees reported
Within city
50% employees reported
View detailed work policy
Top Employees Benefits
Health insurance
21 employees reported
Job/Soft skill training
19 employees reported
Professional degree assistance
4 employees reported
Cafeteria
4 employees reported
View all benefits
About Boehringer-Ingelheim
Founded in1885 (140 yrs old)
India Employee Count501-1k
Global Employee Count10k-50k
HeadquartersIngelheim, Germany
Office Locations
Websiteboehringer-ingelheim.com
Primary Industry
Other Industries
--
Are you managing Boehringer-Ingelheim's employer brand? To edit company information,
claim this page for free
View in video summary
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organisation, the Board of Managing Directors and the company's history as well as our engagement for scientific, cultural and environmental purposes.
Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
Report error
Managing your company's employer brand?
Claim this Company Page for FREE
Boehringer-Ingelheim Ratings
based on 302 reviews
Overall Rating
4.0/5
How AmbitionBox ratings work?
5
147
4
89
3
33
2
11
1
22
Category Ratings
3.9
Salary
3.9
Work-life balance
3.9
Skill development
3.8
Company culture
3.7
Work satisfaction
3.2
Promotions
3.0
Job security
Boehringer-Ingelheim is rated 4.0 out of 5 stars on AmbitionBox, based on 302 company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Boehringer-Ingelheim
based on 284 reviews
4.1
Rated by 35 Women
Rated 4.1 for Company culture and 3.9 for Salary
3.9
Rated by 249 Men
Rated 3.9 for Work-life balance and 3.9 for Skill development
Work Policy at Boehringer-Ingelheim
based on 18 reviews in last 6 months
Work from office
45%
Hybrid
44%
Permanent work from home
11%
Boehringer-Ingelheim Reviews
Top mentions in Boehringer-Ingelheim Reviews
+ 5 more
Compare Boehringer-Ingelheim with Similar Companies
 |  Change Company |  Change Company |  Change Company | |
|---|---|---|---|---|
Overall Rating | 4.0/5 based on 302 reviews | 4.1/5 based on 3.3k reviews  | 3.8/5 based on 3.7k reviews | 4.2/5 based on 3.4k reviews |
Highly Rated for | Skill development Work-life balance Salary | Skill development Work-life balance Salary | Job security | Salary Job security Work-life balance |
Critically Rated for | Job security Promotions | Promotions | Promotions |  No critically rated category |
Primary Work Policy | Work from office 45% employees reported | Work from office 53% employees reported | Work from office 89% employees reported | Work from office 77% employees reported |
Rating by Women Employees | 4.1 Good rated by 35 women | 4.0 Good rated by 417 women | 4.0 Good rated by 385 women | 4.0 Good rated by 342 women |
Rating by Men Employees | 3.9 Good rated by 249 men | 4.1 Good rated by 2.7k men | 3.8 Good rated by 3.1k men | 4.2 Good rated by 2.9k men |
Job security | 3.0 Average | 3.8 Good | 4.0 Good | 4.1 Good |
View more
Boehringer-Ingelheim Salaries
Boehringer-Ingelheim salaries have received with an average score of 3.9 out of 5 by 302 employees.
Business Development Manager
(327 salaries)
Unlock
₹3.4 L/yr - ₹10 L/yr
Area Sales Manager
(60 salaries)
Unlock
₹8.1 L/yr - ₹15.5 L/yr
Senior Business Development Manager
(43 salaries)
Unlock
₹6 L/yr - ₹11 L/yr
Senior Area Sales Manager
(29 salaries)
Unlock
₹12 L/yr - ₹22 L/yr
Medical Representative
(23 salaries)
Unlock
₹3 L/yr - ₹9 L/yr
BDM
(16 salaries)
Unlock
₹4.4 L/yr - ₹7.5 L/yr
Key Account Manager
(16 salaries)
Unlock
₹4.9 L/yr - ₹13 L/yr
Brand Manager
(13 salaries)
Unlock
₹10 L/yr - ₹22 L/yr
Sr.Zonal Sales Manager
(11 salaries)
Unlock
₹25.8 L/yr - ₹35 L/yr
Sr BDM
(10 salaries)
Unlock
₹6.6 L/yr - ₹11.5 L/yr
Prepare for Your Boehringer-Ingelheim Interview with Real Experiences!
View interviews
Boehringer-Ingelheim Jobs
Popular Designations Boehringer-Ingelheim Hires for
Area Sales Manager
Create job alerts
Head
Create job alerts
Popular Skills Boehringer-Ingelheim Hires for
Current Openings
Boehringer-Ingelheim News
Boehringer Ingelheim and Eko Health Partner to Bring AI-Powered Heart Disease Detection to Veterinary Medicine
- Boehringer Ingelheim and Eko Health have announced a strategic collaboration to enhance the early detection and diagnosis of heart disease in dogs by combining expertise in canine cardiology and AI algorithms.
- The partnership will leverage Eko Health’s technology and Boehringer’s proprietary algorithm to develop a canine-specific detection algorithm available to veterinarians through a purpose-built Eko mobile app in 2026.
- Heart murmurs in dogs are a common finding in myxomatous mitral valve disease, affecting approximately 10 to 15% of dogs in their lifetime, making early detection crucial.
- The collaboration aims to equip veterinarians with a powerful tool to detect heart murmurs earlier and with greater confidence, enabling them to hear, see, and document the sounds to share with dog owners for appropriate treatment.
Hitconsultant | 11 Jun, 2025
Zoonotic Threats, Invasive Species, and Food Chain Shocks: Why Animal Biotech Is on Watchlists Now
- The importance of animal disease prevention for public health has been underscored by organizations like Boehringer Ingelheim and the CDC.
- The U.S. released the National One Health Framework to tackle zoonotic diseases and enhance public health readiness.
- Invasive species cost the economy $137 billion annually, leading to a focus on addressing animal health and population control.
- Companies like BioVaxys Technology Corp., Zoetis Inc., and others are innovating in animal biotech to address these challenges.
- Global Animal Health Market is expected to grow significantly, with projections estimating substantial revenue potential.
- BioVaxys' partner SpayVac has expanded its contraceptive vaccine platform into commercial aquaculture and farm-raised fish markets.
- SpayVac's immunocontraceptive vaccine technology offers a scalable alternative for reproductive control in aquaculture.
- BioVaxys' technology also addresses wildlife populations like feral horses and deer, aiming for innovative solutions in animal health.
- Companies like Zoetis and Elanco are developing vaccines for avian influenza, while Neogen is focusing on food and animal safety technologies.
- SenesTech's non-lethal rat birth control initiative in urban areas demonstrates innovative and humane pest control methods.
- Overall, advancements in animal biotech are crucial for addressing zoonotic threats, invasive species, and food chain shocks.
Baystreet | 23 Apr, 2025
Brainomix secures €16.7 milllion to advance its AI imaging technology in healthcare
- Oxford-based Brainomix has secured €16.7 million in a Series C investment round to expand its AI imaging technology in healthcare.
- The investment round was co-led by Parkwalk Advisors, the Boehringer Ingelheim Venture Fund, and Hostplus via the IP Group Hostplus Innovation Fund, along with support from LifeSci Capital.
- Brainomix, a spinout from the University of Oxford, has developed an AI platform called Brainomix 360 Stroke that automates imaging biomarkers to improve diagnosis and treatment decisions for stroke patients. It has been deployed in over 300 hospitals globally.
- The funding will enable Brainomix to expand into the US market, accelerate the development of its AI-powered technology in new areas, and grow its operations and commercial team.
Eu-Startups | 20 Mar, 2025
Mankind Pharma Launches Generic Version Of Empagliflozin Diabetes Medication
- Mankind Pharma has launched a generic version of Empagliflozin, a diabetes medication, in India following the expiration of Boehringer Ingelheim's patent for the drug.
- The generic version is available under the brand names Empaglyde, Empagreat, and Dynaduo, in various strengths (10 mg to 25 mg).
- The launch aims to increase accessibility and affordability, with prices starting at Rs 5.49 for the 10 mg variant and Rs 9.90 for the 25 mg variant.
- Other companies, including Glenmark and Alkem Laboratories, have also introduced generic versions of Empagliflozin in India.
Bloomberg Quint | 12 Mar, 2025
Powered by
Compare Boehringer-Ingelheim with
GlaxoSmithKline Pharmaceuticals
4.1
Teva Pharmaceuticals
4.0
Sanofi
4.2
Fresenius Kabi
4.1
Novo Nordisk
4.0
AstraZeneca
4.0
Eli Lilly and Company
3.7
Sandoz
3.9
Otsuka Pharmaceutical India Private Limited
4.1
Novartis Healthcare
4.1
Agilent Technologies
4.2
Merck
4.2
Apcer Life Sciences
3.6
Universal Corporation
3.6
MSD Pharmaceuticals
4.1
Abbott Nutrition International
4.0
Roche Diagnostics
3.8
Cardinal Health
4.0
Eversana
3.4
Bristol-Myers Squibb
3.8
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Boehringer-Ingelheim
Abbott
Healthcare / Pharma, Media & Entertainment / Publishing, Pharma
4.1
• 3.3k reviews
GlaxoSmithKline Pharmaceuticals
Biotech & Life sciences, Healthcare / Pharma, Manufacturing, Pharma
4.1
• 2k reviews
Teva Pharmaceuticals
Healthcare / Pharma, Clinical Research, Pharma
4.0
• 1.4k reviews
Sanofi
Biotech & Life sciences, Manufacturing, Analytics & KPO, Pharma
4.2
• 1.3k reviews
Fresenius Kabi
Manufacturing, Analytics & KPO, Pharma
4.1
• 1.1k reviews
Novo Nordisk
Internet, Pharma
4.0
• 1k reviews
AstraZeneca
Biotechnology, Pharma
4.0
• 887 reviews
Eli Lilly and Company
Pharma
3.7
• 486 reviews
Sandoz
Pharma
3.9
• 464 reviews
Otsuka Pharmaceutical India Private Limited
Manufacturing, Pharma
4.1
• 441 reviews
Boehringer-Ingelheim FAQs
When was Boehringer-Ingelheim founded?
Boehringer-Ingelheim was founded in 1885. The company has been operating for 140 years primarily in the Pharma sector.
Where is the Boehringer-Ingelheim headquarters located?
Boehringer-Ingelheim is headquartered in Ingelheim and has an office in Bangalore / Bengaluru.
How many employees does Boehringer-Ingelheim have in India?
Boehringer-Ingelheim currently has approximately 500+ employees in India.
Does Boehringer-Ingelheim have good work-life balance?
Boehringer-Ingelheim has a Work-Life Balance Rating of 3.9 out of 5 based on 300+ employee reviews on AmbitionBox. 78% employees rated Boehringer-Ingelheim 4 or above, while 22% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Boehringer-Ingelheim work-life balance reviews for more details.
Is Boehringer-Ingelheim good for career growth?
Career growth at Boehringer-Ingelheim is rated as moderate, with a promotions and appraisal rating of 3.2. 22% employees rated Boehringer-Ingelheim 3 or below, while 78% employees rated it 4 or above on promotions / appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Boehringer-Ingelheim promotions / appraisals reviews for more detailed insights.
What are the pros and cons of working in Boehringer-Ingelheim?
Working at Boehringer-Ingelheim comes with several advantages and disadvantages. It is highly rated for salary & benefits, skill development and work life balance. However, it is poorly rated for job security, promotions / appraisal and work satisfaction, based on 300+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Trusted by over 1.5 Crore job seekers to find their right fit company
80 Lakh+
Reviews
10L+
Interviews
4 Crore+
Salaries
1.5 Cr+
Users
Contribute to help millions
AmbitionBox Awards
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2025 Info Edge (India) Ltd.
Follow Us
